Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.

Lehmann R, Brzosko M, Kopsa P, Nischik R, Kreisse A, Thurston H, Litschig S, Sloan VS.

Curr Med Res Opin. 2005 Apr;21(4):517-26.

PMID:
15899100
2.

Lumiracoxib.

Buvanendran A, Barkin R.

Drugs Today (Barc). 2007 Mar;43(3):137-47. Review.

PMID:
17380211
3.

Lumiracoxib (Prexige): a new selective COX-2 inhibitor.

Mysler E.

Int J Clin Pract. 2004 Jun;58(6):606-11. Review.

PMID:
15311562
4.

Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials.

Xu C, Gu K, Yasen Y, Hou Y.

Medicine (Baltimore). 2016 May;95(20):e3585. doi: 10.1097/MD.0000000000003585. Review.

5.

Lumiracoxib for acute postoperative dental pain: a systematic review of randomized clinical trials.

Silva RC, Riera R, Saconato H.

Sao Paulo Med J. 2011;129(5):335-45. Review.

6.

The safety of lumiracoxib when used in the treatment of arthritis.

Doggrell SA.

Expert Opin Pharmacother. 2005 Feb;6(2):347-50. Review. No abstract available.

PMID:
15757430

Supplemental Content

Support Center